Full Press Release Details
Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, March 31, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Nyxoah S.A. (“Nyxoah” or “the Company”) (NASDAQ: NYXH) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Nyxoah investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: info@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
On March 25, 2025, Nyxoah announced that the U.S. Food and Drug Administration (FDA) had issued an Approvable Letter for its Pre-Market Approval (PMA) application for the Genio® system. The letter indicated that Nyxoah’s application substantially met regulatory requirements, and final approval would be granted pending a satisfactory review of the company’s manufacturing facilities, methods, and controls.
Following the announcement, analysts anticipated a delay in Genio’s commercial launch due to the additional FDA review.
On this news, Nyxoah’s stock price declined by $2.42 per share, or 21.36%, closing at $8.91 on March 26, 2025.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bars
Attorney Advertising